AVEO Oncology (AVEO) Announces Addition of FOTIVDA into National Comprehensive Cancer Network Clinical Practice Guidelines

Go back to AVEO Oncology (AVEO) Announces Addition of FOTIVDA into National Comprehensive Cancer Network Clinical Practice Guidelines
AVEO PHARMA (NASDAQ: AVEO) Delayed: 6.77 -0.68 (9.13%)
Previous Close $7.45    52 Week High $1.42 
Open $7.38    52 Week Low $0.56 
Day High $7.38    P/E N/A 
Day Low $6.69    EPS $-2.28 
Volume 1,032,788